What is Eikon Therapeutics, Inc. 's shares (basic)?

Eikon Therapeutics, Inc. (EIKN) reported shares (basic) of 33.7M in Q1 2026.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

MYR GroupMYRG

15.5M-2.8%

Cabot CorporationCBT

52M-3.7%

HES

Hess MidstreamHESM

129.2M+16.7%

Main Street CapitalMAIN

90.7M+2.2%

BeldenBDC

38.8M-3.4%

UnifirstUNF

18.1M-2.7%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$521.35M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's shares (basic)?: Eikon Therapeutics, Inc. (EIKN) reported shares (basic) of 33.7M in Q1 2026.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.